CYP1A1 is identified as a CCG in both lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), reaffirming our methodology to identify CCGs. This evidence concerns the gene CYP1A1 and squamous cell lung carcinoma.